Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis

Medical Journal
Written By Abby Hunt

Martini AE, Beall S, Ball GD, Hayward B, D'Hooghe T, Mahony MC, Collares F, Catherino AB. Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis. Front Endocrinol (Lausanne). 2023 Sep 1;14:1195632. doi: 10.3389/fendo.2023.1195632. PMID: 37727455; PMCID: PMC10505726.

Abby Hunt
Previous

First Bologna, then Poseidon: What are we still missing to personalize care for patients undergoing assisted reproductive technology with a poor prognosis?
Next

UNLOCKING THE POTENTIAL OF ARTIFICIAL INTELLIGENCE (AI) IN REPRODUCTIVE MEDICINE: THE JARG COLLECTION ON ASSISTED REPRODUCTIVE TECHNOLOGY (ART) AND MACHINE LEARNING